Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.56 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MTOR | P42345 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12959076 | 1.00 | PNP (0.56) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL12820927 | 1.00 | PNP (0.56) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL30326363 | 0.99 | PNP (0.55) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL30867121 | 0.92 | PNP (0.47) | PNPTLR7MEN1KMT2ACYP3A4 | |
| Cytidine SCHEMBL28233906 | 0.91 | LMNA (0.65) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL19552748 | 0.91 | PNP (0.48) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL19183038 | 0.91 | PNP (0.45) | PNPTLR7MEN1KMT2AHINT1 | |
| Triphosphate SCHEMBL31158164 | 0.90 | PNP (0.47) | PNPTLR7MEN1KMT2ALMNA | |
| SCHEMBL29565496 | 0.89 | PNP (0.45) | PNPTLR7MEN1KMT2ACYP3A4 | |
| SCHEMBL29714505 | 0.89 | PNP (0.47) | PNPTLR7MEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15313 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| CN-122095092-A | Inhibitor for inhibiting inhibin Beta E gene expression and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122060818-A | Chemically modified circular RNA molecules, methods of making and uses thereof | 上海元码智药生物技术有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4739794-A1 | METHODS, COMPOSITONS, AND SYSTEMS FOR ANALYTE DETECTION | Stellaromics, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4739343-A2 | CIRCULAR RNA VACCINES FOR SEASONAL FLU AND METHODS OF USES | Shanghai Circode Biomed Co., Ltd (CN) | 2026-05-13 | — | — | EP | claimed |
| WO-2026090312-A1 | MODULAR RNA MODIFICATION MODEL TRAINING FRAMEWORK | NORTHEASTERN UNIVERSITY (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4689071-A2 | MRNA THERAPEUTICS FOR OOCYTE MATURATION | Eastern Virginia Medical School (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4684016-A2 | METHODS AND MATERIALS FOR TREATING CANCER | The Regents of the University of California (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260014185-A1 | Delivery of RNA to Different Cell Types | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2026-01-15 | — | — | US | claimed |
| EP-0842286-A2 | COMPOSITIONS AND METHOD FOR MODULATION OF GENE EXPRESSION IN PLANTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | claimed |
| WO-1997024455-A2 | METHODS AND COMPOSITIONS FOR FULL-LENGTH cDNA CLONING | CLONTECH LABORATORIES, INC. (US) | 1997-07-10 | — | — | WO | claimed |
| WO-1997010328-A2 | COMPOSITIONS AND METHOD FOR MODULATION OF GENE EXPRESSION IN PLANTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-03-20 | — | — | WO | claimed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | claimed |
| WO-1994006811-A1 | SILOXY OLIGONUCLEOTIDE ANALOGS | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 1994-03-31 | — | — | WO | claimed |
| EP-0531447-A4 | COMPOSITIONS AND METHODS FOR MODULATING RNA ACTIVITY THROUGH MODIFICATION OF THE 5' CAP STRUCTURE OF RNA | — | 1993-08-11 | — | — | EP | claimed |
| EP-0531447-A1 | COMPOSITIONS AND METHODS FOR MODULATING RNA ACTIVITY THROUGH MODIFICATION OF THE 5' CAP STRUCTURE OF RNA | ISIS PHARMACEUTICALS, INC. (US) | 1993-03-17 | — | — | EP | claimed |
| US-5075225-A | PROCESS FOR THE ENZYMATIC SYNTHESIS OF NUCLEOSIDES | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1991-12-24 | — | — | US | claimed |
| WO-1991017755-A1 | COMPOSITIONS AND METHODS FOR MODULATING RNA ACTIVITY THROUGH MODIFICATION OF THE 5' CAP STRUCTURE OF RNA | ISIS PHARMACEUTICALS, INC. (US) | 1991-11-28 | — | — | WO | claimed |